Abstract:Objectives: Cystatin C (Cys C) and high-density lipoprotein (HDL) play critical roles in neurodegenerative diseases, such as dementia, Alzheimer’s disease (AD) and vascular dementia (VaD). However, whether they can be used as reliable biomarkers to distinguish patients with dementia from healthy subjects and to determine disease severity remain largely unknown. Methods: We conducted a cross-sectional study to determine plasma Cys C and HDL levels of 88 patients with dementia (43 AD patients, 45 VaD patients) and 45 healthy age-matched controls. The severity of dementia was determined based on the Schwab and England Activities of Daily Living (ADL) Scale, the Mini-mental State Examination (MMSE), the Global Deterioration Scale (GDS), the Lawton Instrumental ADL (IADL) Scale, and the Hachinski Ischemia Scale (Hachinski). Receiver operating characteristic (ROC) curves were calculated to determine the diagnostic accuracy of Cys C and HDL levels in distinguishing patients with dementia from healthy subjects. Results: We found that plasma Cys C levels were higher, but HDL levels were lower in AD and VaD patients respectively, compared to healthy control subjects. Yet, Cys C levels were highest among patients with VaD. Interestingly, plasma Cys C levels were significantly correlated with IADL Scale scores. In addition, the ROC curves for Cys C (area under the curve, AUC 0.816 for AD, AUC 0.841 for VaD) and HDL (AUC 0.800 for AD, AUC 0.731 for VaD) exhibited potential diagnostic value in distinguishing AD/VaD patients from healthy subjects. While the ROC curve for the combination of Cys C and HDL (AUC 0.873 for AD, AUC 0.897 for VaD) showed higher diagnostic accuracy in distinguishing AD/VaD patients from healthy subjects than the separate curves for each parameter. Conclusions: Our findings suggest that the inflammatory mediators Cys C and HDL may play important roles in the pathogenesis of dementia, and plasma Cys C and HDL levels may be useful screening tools for differentiating AD/VaD patients from healthy subjects. Highlights Plasma Cys C levels were higher in patients with AD/VaD than in healthy subjects. Plasma HDL levels were lower in patients with AD/VaD than in healthy subjects. Plasma Cys C levels were significantly correlated with dementia. The ROC curve for the combination of Cys C and HDL showed potential diagnostic value in distinguishing AD/VaD from healthy subjects.

Clinical values of serum C5a in Alzheimer's disease patients with different dementia stages

Diagnostic potential of urinary monocyte chemoattractant protein-1 for Alzheimer's disease and amnestic mild cognitive impairment

Levation of serum macrophage colony stimulating factor level in patients with Alzheimer's disease

Research on the levels of TNF-α, IL-1β and IL-8 in serum and CSF of patients with Alzheimer' s disease

Levels of the tumor necrosis factor alpha and interleukin-8 in serum and cerebrospinal fluid of patients with Alzheimer disease

Inflammatory Cytokines and Cognition in Alzheimer's Disease and Its Prodrome

Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients

Serum levels of complement C3 and Aβ1-42 in patients with Alzheimer disease

The Association of Blood-Based Inflammatory Factors IL-1β, TGF-β and CRP with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment

Detection of interleukin-1β and tumor necrosis factor α in serum and cerebrospinal fluid in patients with Alzheimer disease

Inflammatory Markers in Alzheimer’s Disease and Mild Cognitive Impairment: a Meta-Analysis and Systematic Review of 170 Studies

Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer’s disease

Increased Serum Levels Of Interleukin-18,-23 And-17 In Chinese Patients With Alzheimer'S Disease

A Meta-Analysis of C-Reactive Protein in Patients with Alzheimer's Disease.

Plasma Complement C3 Levels in Alzheimer's Disease

Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer’s Disease and Vascular Dementia: A Cross-Sectional Study

A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer’s Disease

Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition

Changes of Pro-and Anti-Inflammatory Cytokines in Serum and Cerebrospinal Fluid of Patients with Different Kinds of Dementias

Association of Plasma Apolipoproteins and Levels of Inflammation-Related Factors with Different Stages of Alzheimer’s Disease: a Cross-Sectional Study

Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 Levels in Alzheimer's: The Relation Between Neuroinflammatory Pathway and Severity of Dementia